Liquid formulation of decitabine and use of the same

Details for Australian Patent Application No. 2003249680 (hide)

International Classifications

Event Publications

16 October 2003 Complete Application Filed

Priority application(s): 10/164,276 05.06.02 US

19 February 2004 Application Open to Public Inspection

Published as AU-B-2003249680

23 November 2006 Application Accepted

Published as AU-B-2003249680

4 January 2007 Application for Amendment

The nature of the amendment is as shown in the statement(s) filed 06 Dec 2006. Address for service in Australia - Davies Collison Cave 1 Nicholson Street MELBOURNE VIC 3000 2004

26 April 2007 Standard Patent Sealed

31 May 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 06 Dec 2006

21 June 2007 Amendment Made

The nature of the amendment is as shown in the statement(s) filed 07 Dec 2006

28 June 2007 Corrigenda

Amendments, Section 104 - Amendments Made Under the name SuperGen, Inc., Application No. 2003249680, delete all reference to Specifications Republished The following specifications contained errors when advertised OPI, Accepted or Certified. They have been reissued on the AU-A or AU-B CD-ROM of this Journal date. 2002233090 Delaney Machinerie Inc. 2002252800 DSM IP Assets B.V. 2002302903 Pfizer Products Inc. 2003249680 SuperGen, Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.